title: [Psoriasis is associated with type 2 diabetes].
abstract: Psoriasis is a chronic inflammatory skin disease with a global prevalence of 2-3%. In recent years it has been established that patients with psoriasis carry an increased risk of type 2 diabetes, but the underlying pathophysiological mechanisms remain unclear. The association is most likely due to a combination of shared genes, immunoinflammatory mechanisms and a number of diabetes risk factors in patients with psoriasis. The current review summarises the evidence in the field and calls for attention on diabetes risk assessment, preventive measures and treatment in patients with psoriasis.
authors: Dermato-allergologisk Afdeling K, Gentofte Hospital, Niels Andersens Vej 65, 2900 Hellerup, Denmark. mette.gyldenloeve@regionh.dk
authors: Mette
authors: M
authors: Gyldenløve
authors: Filip Krag
authors: FK
authors: Knop
authors: Tina
authors: T
authors: Vilsbøll
authors: Claus
authors: C
authors: Zachariae
authors: Lone
authors: L
authors: Skov
mesh_terms: D000428:Alcohol Drinking / Q000009:adverse effects; D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000188:drug therapy; D052216:Glucagon-Like Peptide 1 / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D054795:Incretins / Q000627:therapeutic use; D024821:Metabolic Syndrome / Q000150:complications; D009765:Obesity / Q000150:complications; D011565:Psoriasis / Q000150:complications* / Q000188:drug therapy / Q000235:genetics / Q000473:pathology; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects
chemical_list: D005938:Glucocorticoids; D054795:Incretins; D052216:Glucagon-Like Peptide 1